Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Compound Paracetamol Tablets

Approval Number

国药准字H20184014

Company重庆希尔安药业有限公司

Registration Date

December 1, 2022

Previous Approval Numbers

国药准字H21021167

Drug Information

Generic Name

复方对乙酰氨基酚片

Dosage Form

片剂

Strength

对乙酰氨基酚0.126克，阿司匹林0.23克，咖啡因30毫克

Drug Type

化学药品

Registration Date

December 1, 2022

Company Information

Applicant Company

Company Name重庆希尔安药业有限公司

Company Address

重庆市合川工业园区希尔安路168号

Manufacturing Company

Company Name重庆希尔安药业有限公司

Company Address

重庆市合川工业园区希尔安路168号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy